Effect of Hydroxychloroquine on Pluripotent Stem Cells and Their Cardiomyocytes Derivatives

Overview

Journal Front Pharmacol

Date 2023 Jul 28

PMID 37502208

Authors

Michelle Vanessa Kamga Kapchoup

Jurgen Hescheler

Filomain Nguemo

Affiliations

Soon will be listed here.

Abstract

Hydroxychloroquine (HDQ) is an antimalarial drug that has also shown its effectiveness in autoimmune diseases. Despite having side effects such as retinopathy, neuromyopathy and controversial cardiac toxicity, HDQ has been presented and now intensively studied for the treatment and prevention of coronavirus disease 2019 (COVID-19). Recent works revealed both beneficial and toxic effects during HDQ treatment. The cardiotoxic profile of HDQ remains unclear and identifying risk factors is challenging. Here, we used well-established cell-cultured to study the cytotoxic effect of HDQ, mouse induced pluripotent stem cells (miPSC) and their cardiomyocytes (CMs) derivatives were exposed to different concentrations of HDQ. Cell colony morphology was assessed by microscopy whereas cell viability was measured by flow cytometry and impedance-based methods. The effect of HDQ on beating activity of mouse and human induced pluripotent stem cell-derived CMs (miPSC-CMs and hiPSC-CMs, respectively) and mouse embryonic stem cell-derived CMs (mESC-CMs) were captured by the xCELLigence RTCA and microelectrode array (MEA) systems. Our results revealed that 20 µM of HDQ promotes proliferation of stem cells used suggesting that if appropriately monitored, HDQ may have a cardioprotective effect and may also represent a possible candidate for tissue repair. In addition, the field potential signals revealed that higher doses of this medication caused bradycardia that could be reversed with a higher concentration of ß-adrenergic agonist, Isoproterenol (Iso). On the contrary, HDQ caused an increase in the beating rate of hiPSC-CMs, which was further helped upon application of Isoproterenol (Iso) suggesting that HDQ and Iso may also work synergistically. These results indicate that HDQ is potentially toxic at high concentrations and can modulate the beating activity of cardiomyocytes. Moreover, HDQ could have a synergistic inotropic effect with isoproterenol on cardiac cells.

References

Liu Q, Bi G, Chen G, Guo X, Tu S, Tong X . Time-Dependent Distribution of Hydroxychloroquine in Cynomolgus Macaques Using Population Pharmacokinetic Modeling Method. Front Pharmacol. 2021; 11:602880. PMC: 7841297. DOI: 10.3389/fphar.2020.602880. View

DUBOIS E . Antimalarials in the management of discoid and systemic lupus erythematosus. Semin Arthritis Rheum. 1978; 8(1):33-51. DOI: 10.1016/0049-0172(78)90033-1. View

Chen C, Wang F, Lin C . Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol (Phila). 2006; 44(2):173-5. DOI: 10.1080/15563650500514558. View

Wernig M, Meissner A, Foreman R, Brambrink T, Ku M, Hochedlinger K . In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature. 2007; 448(7151):318-24. DOI: 10.1038/nature05944. View

Folkerts H, Hilgendorf S, Wierenga A, Jaques J, Mulder A, Coffer P . Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia. Cell Death Dis. 2017; 8(7):e2927. PMC: 5550863. DOI: 10.1038/cddis.2017.317. View

Sutanto H, Heijman J . Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin. Front Physiol. 2020; 11:587709. PMC: 7642988. DOI: 10.3389/fphys.2020.587709. View

Pfannkuche K, Liang H, Hannes T, Xi J, Fatima A, Nguemo F . Cardiac myocytes derived from murine reprogrammed fibroblasts: intact hormonal regulation, cardiac ion channel expression and development of contractility. Cell Physiol Biochem. 2009; 24(1-2):73-86. DOI: 10.1159/000227815. View

Fatima A, Xu G, Nguemo F, Kuzmenkin A, Burkert K, Hescheler J . Murine transgenic iPS cell line for monitoring and selection of cardiomyocytes. Stem Cell Res. 2016; 17(2):266-272. DOI: 10.1016/j.scr.2016.07.007. View

Wong A, Gurung B, Wong W, Mak S, Tse W, Li C . Adverse effects of hydroxychloroquine and azithromycin on contractility and arrhythmogenicity revealed by human engineered cardiac tissues. J Mol Cell Cardiol. 2020; 153:106-110. PMC: 7765761. DOI: 10.1016/j.yjmcc.2020.12.014. View

10.

Jordaan P, Dumotier B, Traebert M, Miller P, Ghetti A, Urban L . Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes. Toxicol Sci. 2021; 180(2):356-368. PMC: 7928616. DOI: 10.1093/toxsci/kfaa194. View

11.

Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa M . A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic. Int J Antimicrob Agents. 2020; 56(2):106028. PMC: 7243790. DOI: 10.1016/j.ijantimicag.2020.106028. View

12.

Furst D . Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases. Lupus. 1996; 5 Suppl 1:S11-5. View

13.

Hamad S, Derichsweiler D, Papadopoulos S, Nguemo F, Saric T, Sachinidis A . Generation of human induced pluripotent stem cell-derived cardiomyocytes in 2D monolayer and scalable 3D suspension bioreactor cultures with reduced batch-to-batch variations. Theranostics. 2019; 9(24):7222-7238. PMC: 6831300. DOI: 10.7150/thno.32058. View

14.

Wolfe F, Marmor M . Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010; 62(6):775-84. DOI: 10.1002/acr.20133. View

15.

Mok C, Mak A, Ma K . Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus. Lupus. 2005; 14(2):106-12. DOI: 10.1191/0961203305lu2039oa. View

16.

Lakshminarayanan S, Walsh S, Mohanraj M, Rothfield N . Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol. 2001; 28(1):102-8. View

17.

Both T, Zillikens M, Hoorn E, Zietse R, van Laar J, Dalm V . Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis. Calcif Tissue Int. 2016; 98(6):573-9. PMC: 4860192. DOI: 10.1007/s00223-016-0112-z. View

18.

Phillips B, Chun D . Hydroxychloroquine retinopathy after short-term therapy. Retin Cases Brief Rep. 2014; 8(1):67-9. DOI: 10.1097/ICB.0000000000000006. View

19.

Al-Rawi H, Meggitt S, Williams F, Wahie S . Steady-state pharmacokinetics of hydroxychloroquine in patients with cutaneous lupus erythematosus. Lupus. 2017; 27(5):847-852. DOI: 10.1177/0961203317727601. View

20.

Merino J, Martinez-Cossiani M, Iniesta A, Escobar C, Rey J, Castrejon-Castrejon S . COVID-19 and QT interval prolongation: more than just drug toxicity?. Europace. 2020; 22(10):1479. PMC: 7314041. DOI: 10.1093/europace/euaa145. View